vs
Side-by-side financial comparison of Tonix Pharmaceuticals Holding Corp. (TNXP) and Twin Vee PowerCats, Co. (VEEE). Click either name above to swap in a different company.
Tonix Pharmaceuticals Holding Corp. is the larger business by last-quarter revenue ($5.4M vs $3.0M, roughly 1.8× Twin Vee PowerCats, Co.). Twin Vee PowerCats, Co. runs the higher net margin — -85.6% vs -870.3%, a 784.7% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs 60.4%). Twin Vee PowerCats, Co. produced more free cash flow last quarter ($-1.9M vs $-41.5M). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs -24.3%).
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Twin Vee PowerCats Co. is a leading manufacturer of high-performance recreational power catamaran boats. The company offers a diverse lineup of catamaran models suited for leisure cruising, fishing, water sports, and commercial marine use, serving customers primarily across North America, with a growing distribution network in global coastal markets.
TNXP vs VEEE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $3.0M |
| Net Profit | $-46.9M | $-2.6M |
| Gross Margin | 80.4% | 3.7% |
| Operating Margin | -895.8% | -87.7% |
| Net Margin | -870.3% | -85.6% |
| Revenue YoY | 108.8% | 60.4% |
| Net Profit YoY | -112.2% | -119.0% |
| EPS (diluted) | $-4.28 | $-1.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4M | $3.0M | ||
| Q3 25 | $3.3M | $3.4M | ||
| Q2 25 | $2.0M | $4.8M | ||
| Q1 25 | $2.4M | $3.6M | ||
| Q4 24 | $2.6M | $1.9M | ||
| Q3 24 | $2.8M | $2.9M | ||
| Q2 24 | $2.2M | $4.3M | ||
| Q1 24 | $2.5M | $5.3M |
| Q4 25 | $-46.9M | $-2.6M | ||
| Q3 25 | $-32.0M | $-2.8M | ||
| Q2 25 | $-28.3M | $-1.7M | ||
| Q1 25 | $-16.8M | $-1.6M | ||
| Q4 24 | $-22.1M | $-1.2M | ||
| Q3 24 | $-14.2M | $-3.0M | ||
| Q2 24 | $-78.8M | $-4.5M | ||
| Q1 24 | $-14.9M | $-2.3M |
| Q4 25 | 80.4% | 3.7% | ||
| Q3 25 | 58.4% | -1.3% | ||
| Q2 25 | -63.8% | 13.8% | ||
| Q1 25 | 61.2% | 14.9% | ||
| Q4 24 | 54.2% | -57.6% | ||
| Q3 24 | 44.9% | -5.0% | ||
| Q2 24 | -52.5% | 4.7% | ||
| Q1 24 | 33.1% | 5.3% |
| Q4 25 | -895.8% | -87.7% | ||
| Q3 25 | -1005.1% | -81.0% | ||
| Q2 25 | -1416.2% | -35.2% | ||
| Q1 25 | -660.9% | -46.5% | ||
| Q4 24 | -870.6% | -224.9% | ||
| Q3 24 | -551.2% | -107.3% | ||
| Q2 24 | -3501.6% | -107.7% | ||
| Q1 24 | -860.2% | -48.2% |
| Q4 25 | -870.3% | -85.6% | ||
| Q3 25 | -972.9% | -80.4% | ||
| Q2 25 | -1415.0% | -34.8% | ||
| Q1 25 | -692.8% | -44.6% | ||
| Q4 24 | -856.2% | -62.7% | ||
| Q3 24 | -503.6% | -103.7% | ||
| Q2 24 | -3567.8% | -104.4% | ||
| Q1 24 | -601.9% | -44.3% |
| Q4 25 | $-4.28 | $-1.19 | ||
| Q3 25 | $-3.59 | $-1.23 | ||
| Q2 25 | $-3.86 | $-0.87 | ||
| Q1 25 | $-2.84 | $-1.08 | ||
| Q4 24 | $2302.65 | $-3.51 | ||
| Q3 24 | $-22.68 | $-2.64 | ||
| Q2 24 | $-1920.85 | $-3.09 | ||
| Q1 24 | $-535.72 | $-1.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $207.6M | $1.4M |
| Total DebtLower is stronger | — | $499.9K |
| Stockholders' EquityBook value | $245.2M | $13.5M |
| Total Assets | $277.2M | $16.2M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $207.6M | $1.4M | ||
| Q3 25 | $190.1M | $2.7M | ||
| Q2 25 | $125.3M | $6.0M | ||
| Q1 25 | $131.7M | $4.9M | ||
| Q4 24 | $98.8M | $7.5M | ||
| Q3 24 | $28.2M | $11.1M | ||
| Q2 24 | $4.2M | $14.9M | ||
| Q1 24 | $7.0M | $17.1M |
| Q4 25 | — | $499.9K | ||
| Q3 25 | — | $499.9K | ||
| Q2 25 | — | $499.9K | ||
| Q1 25 | — | $499.9K | ||
| Q4 24 | $8.7M | $499.9K | ||
| Q3 24 | $9.4M | $499.9K | ||
| Q2 24 | $10.1M | $499.9K | ||
| Q1 24 | $10.8M | $499.9K |
| Q4 25 | $245.2M | $13.5M | ||
| Q3 25 | $231.1M | $15.9M | ||
| Q2 25 | $168.0M | $18.6M | ||
| Q1 25 | $180.4M | $17.7M | ||
| Q4 24 | $139.6M | $19.2M | ||
| Q3 24 | $74.2M | $17.4M | ||
| Q2 24 | $42.1M | $19.6M | ||
| Q1 24 | $108.1M | $22.3M |
| Q4 25 | $277.2M | $16.2M | ||
| Q3 25 | $252.4M | $18.9M | ||
| Q2 25 | $187.4M | $22.4M | ||
| Q1 25 | $192.9M | $23.6M | ||
| Q4 24 | $162.9M | $25.9M | ||
| Q3 24 | $95.0M | $30.1M | ||
| Q2 24 | $70.3M | $33.8M | ||
| Q1 24 | $135.3M | $36.5M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | 0.06× | 0.03× | ||
| Q3 24 | 0.13× | 0.03× | ||
| Q2 24 | 0.24× | 0.03× | ||
| Q1 24 | 0.10× | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.6M | $-1.7M |
| Free Cash FlowOCF − Capex | $-41.5M | $-1.9M |
| FCF MarginFCF / Revenue | -770.4% | -62.5% |
| Capex IntensityCapex / Revenue | 34.8% | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.2M | $-9.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.6M | $-1.7M | ||
| Q3 25 | $-28.8M | $-2.6M | ||
| Q2 25 | $-14.8M | $-745.6K | ||
| Q1 25 | $-16.6M | $-1.7M | ||
| Q4 24 | $-14.6M | $-2.3M | ||
| Q3 24 | $-18.8M | $-2.4M | ||
| Q2 24 | $-9.9M | $-482.1K | ||
| Q1 24 | $-17.6M | $-1.7M |
| Q4 25 | $-41.5M | $-1.9M | ||
| Q3 25 | $-29.7M | $-3.1M | ||
| Q2 25 | $-15.4M | $-1.5M | ||
| Q1 25 | $-16.6M | $-2.6M | ||
| Q4 24 | $-14.6M | $-3.6M | ||
| Q3 24 | $-18.8M | $-3.7M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | $-17.7M | $-3.7M |
| Q4 25 | -770.4% | -62.5% | ||
| Q3 25 | -904.1% | -91.2% | ||
| Q2 25 | -768.8% | -30.6% | ||
| Q1 25 | -682.8% | -71.0% | ||
| Q4 24 | -566.7% | -192.8% | ||
| Q3 24 | -666.5% | -128.8% | ||
| Q2 24 | — | -51.0% | ||
| Q1 24 | -712.4% | -70.9% |
| Q4 25 | 34.8% | 4.6% | ||
| Q3 25 | 29.2% | 14.0% | ||
| Q2 25 | 26.4% | 14.9% | ||
| Q1 25 | 0.2% | 22.9% | ||
| Q4 24 | 0.1% | 68.8% | ||
| Q3 24 | 0.3% | 45.8% | ||
| Q2 24 | 0.0% | 39.9% | ||
| Q1 24 | 4.4% | 37.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
VEEE
Segment breakdown not available.
